ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2023

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis.

Nami Masumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.